Accessibility Menu
 
AngioDynamics logo

AngioDynamics

(NASDAQ) ANGO

Current Price$10.44
Market Cap$423.11M
Since IPO (2004)-18%
5 Year-57%
1 Year+10%
1 Month-3%

AngioDynamics Financials at a Glance

Market Cap

$423.11M

Revenue (TTM)

$313.73M

Net Income (TTM)

$31.39M

EPS (TTM)

$-0.76

P/E Ratio

-13.48

Dividend

$0.00

Beta (Volatility)

1.04 (Average)

Price

$10.44

Volume

48,560

Open

$10.34

Previous Close

$10.24

Daily Range

$10.34 - $10.78

52-Week Range

$8.36 - $13.99

ANGO: Motley Fool Moneyball Superscore

58

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About AngioDynamics

Industry

Healthcare Equipment and Supplies

Employees

675

CEO

James Christopher Clemmer

Headquarters

Latham, NY 12110, US

ANGO Financials

Key Financial Metrics (TTM)

Gross Margin

53%

Operating Margin

-8%

Net Income Margin

-10%

Return on Equity

-17%

Return on Capital

-13%

Return on Assets

-12%

Earnings Yield

-7.42%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$423.11M

Shares Outstanding

41.32M

Volume

48.56K

Short Interest

0.00%

Avg. Volume

457.51K

Financials (TTM)

Gross Profit

$157.71M

Operating Income

$39.95M

EBITDA

$1.74M

Operating Cash Flow

$10.13M

Capital Expenditure

$4.46M

Free Cash Flow

$14.59M

Cash & ST Invst.

$55.89M

Total Debt

$0.00

AngioDynamics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$78.42M

+8.9%

Gross Profit

$41.48M

+6.7%

Gross Margin

52.89%

N/A

Market Cap

$423.11M

N/A

Market Cap/Employee

$565.65K

N/A

Employees

748

N/A

Net Income

$8.08M

-83.4%

EBITDA

$838.00K

-154.7%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Net Cash

$37.81M

-4.9%

Accounts Receivable

$45.55M

-7.0%

Inventory

$58.58M

-7.2%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-12.04%

N/A

Return on Invested Capital

-13.03%

N/A

Free Cash Flow

$4.13M

+72.4%

Operating Cash Flow

$3.11M

+76.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FULCFulcrum Therapeutics, Inc.
$7.85+1.55%
NMRANeumora Therapeutics, Inc. Common Stock
$2.02-2.18%
SYSo-Young International Inc.
$2.75+2.42%
VREXVarex Imaging Corporation
$11.67+2.17%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.52+0.07%
TQQQProShares Trust - ProShares UltraPro Qqq
$53.06+0.05%
ORCLOracle
$161.83+0.04%
TSLATesla
$363.88+0.03%

Questions About ANGO

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.